Women are still hugely under-represented in STEM (Science, Technology, Engineering and Mathematics) careers. Only 22% of the UK STEM workforce is made up of women according to a 2018 study. In Engineering specifically, the stats are worse: only 12% of all professional engineers are women. Here at Cambridge Design Partnership,…
WEBINAR 6 steps to build winning biosimilar defence strategies through user and technology mapping With Pari Datta 14 MAY 2019 The market for biosimilars is growing rapidly at over 30% per annum, as increasingly more biological drugs are going off-patent and the rate of regulatory approvals increases. The major high-value…
The Drug Delivery and Formulation Summit held in Berlin from March 12-14th offered a great opportunity to catch up on the current state of the industry. As a panellist in two sessions at the conference, here are the key regulatory insights I took away. The impact of changing regulations The…
This article was first published on Drug Development and Delivery.“Those who expect moments of change to be comfortable and free of conflict have not learned their history.” For many involved in the medical and pharmaceutical industries within the last few years, this quote – attributed to American historian Joan Wallach…
With inhaler use notoriously prone to user error, any clinical study that involves self-administration via an inhaler is challenging from the outset. Help is at hand, however, with a simple-but-smart device developed by Cambridge Design Partnership “So many things can go wrong when an inhaler is used to deliver a…
How fast is fast? I’ve always been told that when it comes to drug delivery devices, ‘fast’ development is usually measured in years rather than months – with additional years for industrialisation and transfer to manufacturing. In fact, there are drug delivery devices which have been in development for more…
This month’s Manufacturing Medicines Industry Partnership (MMIP) conference – Propelling growth: taking the next step in innovative medicines manufacturing – took place at an exciting time for the pharma industry. Advanced therapies (ATs) – such as cell therapies in which patients are treated with living cells – have been under development for…
The rise of connected devices and the variety of information they can generate is set to drive an increase in patient adherence to therapies. Our trials have shown that remote and hidden sensing of actual user behaviour can uncover unexpected and significant opportunities to improve the patient experience.So how can…
www.linkedin.com/in/conor-devine-0566b286/As Europe’s dedicated pharmaceutical packaging and drug delivery event, Pharmapack is the industry’s go-to place to kick off the year. At least that’s what the event website says and, after my visit, I’m inclined to agree. With 411 companies exhibiting their services in everything from primary, secondary and tertiary packaging…
Coming back from the Christmas and New Year break, I realised how blessed I am. I’m in good health, I’ve been able to spend enjoyable time with my family and I’ve now returned to my exciting job surrounded by a team of enthusiastic and very smart people. For many people,…
On returning from Vienna and PDA’s excellent Universe of Pre-filled Syringes and Injection Devices event, I wanted to share my thoughts on some of the themes I saw emerging from the conference:1. Hearing the voice of the patient direct – during the pre-conference workshop, Markus Bauss from SHL presented two talks by…
Technology and product design firm Cambridge Design Partnership (CDP) has announced the appointment of drug delivery industry veteran Bastiaan de Leeuw as it embarks on a new phase of growth in the sector. As head of drug delivery business development, he will be driving CDP’s expansion into new markets around…